High-performing cultures aren't built solely on motivation. They need two things: connection and courage. s.hbr.org/3V0Xagk

Link below to our new preprint on the rise of #VibeScience. "We explore how LLMs risk creating research that looks rigorous but lacks epistemic depth. The spread of this phenomenon could reshape how knowledge is generated/validated, with implications for scientific integrity."

Don't miss this review on #ArtificialIntelligence as treatment support in #BreastCancer. 🔓pubmed.ncbi.nlm.nih.gov/40882392/ Giacomo de Micheli Chiara Corti Sara Tolaney G Curigliano MD PhD Sibylle Loibl Paolo Tarantino #JosePabloLeone

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer NEJM doi.org/10.1056/NEJMdo… 👉Low-dose aspirin resulted in a significantly lower risk of recurrence w/ hotspot mutations 👉similar benefit w/ other alterations in PI3K pathway 🧐I would take it... ESMO - Eur. Oncology

Patients at Mass General Brigham will soon be billed extra for online consultations between their doctors and specialists — a change in policy that was swiftly criticized by primary care physicians. trib.al/LqlpOVd

Experimental gene therapy for Huntington’s markedly slowed disease progression in key trial statnews.com/2025/09/24/hun…

Wolters Kluwer has announced a new UpToDate decision support AI tool. It is based exclusively on #UpToDate evidence-based content and allows users to interact quickly in a chat interface. wolterskluwer.com/en/expert-insi…

Most important study I have seen this week. Randomized Phase II Ribo 400mg versus 600mg. Same 1L PFS in 1st Line MBC! Ribo 40g has less toxicity: less grade 3 LFTs, lower qTC prolongation, less neutropenia. Slightly lower ORR with lower dose. #bcsm

LBA1 #ESMO25 for DESTINY-Breast05 astrazeneca.com/media-centre/p…

Great experience participating in the U.S. FDA / ASCO Fellows’ Day Workshop. Engaging case-based discussions on approval pathways and the regulatory decision process. Thanks to Tatiana Prowell, MD and the organizers for such an interactive and insightful workshop. Dana-Farber’s Breast Oncology Center

📣Another step forward for #precision_immunotherapy in breast cancer! 🚀Just out in npj Journals Breast Cancer our exploratory analysis of the NeoTRIP trial showing the role of tumor-specific MHC-II as a predictor of immunotherapy benefit in #TNBC. 📌rdcu.be/eIKAH

Agree 💯. It’s the close collaboration between academic basic research & biotech/pharma that drives progress and therapeutic advancements in modern medicine. #Nobel2025

Our team is deeply grateful for this funding, which will support sequencing and computational work aimed at addressing urgent questions in a patient population already at high risk of relapse. Jorge Gómez Tejeda Zañudo Daniel Abravanel, MD/PhD Sara Tolaney

Thanks, Dr. Angie DeMichele, MD, MSCE, FASCO , for acknowledging our study. I love how you approach data discussions with a pragmatic, RW perspective and a focus on what matters most clinically—such as disease biology and patient outcomes after recurrence here. 🙏🏻 #ESMO25

This class of drugs going broadly into multiple other tumor types/histologies. Exciting to see what may be possible with PD-1/VEGFs (multiple ones) and the PD-L1/VEGF. Especially in tumors that have had "less benefit" to immune- #bcsm #ESMO25 #ESMOAmbassadors

This is amazing - a periodic table showing every element and how it’s used. Chemistry really is everywhere. 🔬✨ What’s your favorite element?

📣 FDA has approved a new non-hormonal pill, elinzanetant, to treat #menopause symptoms. The med is an NK3 receptor antagonist that works on the brain’s “thermostat” to decrease hot flashes/night sweats from low estrogen. #bcsm #MedTwitter #regulatory 1/2 nytimes.com/2025/10/24/wel…

Joined Harold J. Burstein, MD, PhD, FASCO contest during #ESMO25 ESMO - Eur. Oncology review: proposed algorithm for first- and second-line #EndocrineTherapy in ER-positive/HER2-negative metastatic #BreastCancer OncoAlert

Feeling incredibly #grateful for this #award — but even more grateful for the amazing #team behind every research effort.💫 #SABCS25 SABCS AACR

November 2 — Commemoration of All the Departed in Italy. Remembering those I’ve lost too soon, and thinking of those who carry the weight of grief. May memory be a quiet form of love. 🕯️🇮🇹